Risk of Death Following Application of Paclitaxel-Coated Balloons and Stents

Risk of Death Following Application of Paclitaxel-Coated Balloons and Stents in the Femoropopliteal Artery of the Leg: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Background: Several randomized controlled trials (RCTs) have already shown that paclitaxel-coated balloons and stents significantly reduce the rates of vessel restenosis and target lesion revascularization after lower extremity interventions.

Conclusions: There is increased risk of death following application of paclitaxel-coated balloons and stents in the femoropopliteal artery of the lower limbs. Further investigations are urgently warranted.
Author(s)Source
Katsanos K, Spiliopoulos S, Kittriou P, Krokidis M, Karnabatidis DJ Am Heart Assoc. 2018;7:e011245. DOI: 10.1161/JAHA.118.011245. 
www.crd.york.ac.uk/PROSPERO. Unique identifier: CRD42018099447
This is a post of a scientific or business information. The information given here is checked thoroughly by “Implant-Register”. However we can´t be responsible for the content. The content usually is shortened to make it understandable for many. Read the linked original text if you are interested. Contact the publisher, if you have questions. You may inform us about changes of the information to improve the Register.
Comments: n/a
let us know
Scroll to Top